14.02
Anika Therapeutics Inc Aktie (ANIK) Neueste Nachrichten
Anika Therapeutics (NASDAQ:ANIK) Upgraded at B. Riley - Defense World
B. Riley Initiates Coverage on Anika Therapeutics (NASDAQ:ANIK) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2024 Earnings Call Transcript - MSN
B. Riley Initiates Anika Therapeutics at Buy With $21 Price Target - marketscreener.com
Anika Therapeutics (ANIK) Receives 'Buy' Rating with $21 Target from B. Riley Analyst | ANIK Stock News - GuruFocus
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Purchased by Wellington Management Group LLP - Defense World
Viscosupplementation Market Is Booming Worldwide 2025-2032 | - openPR.com
Arrowstreet Capital Limited Partnership Has $979,000 Stock Holdings in Anika Therapeutics, Inc. (NASDAQ:ANIK) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Bought by American Century Companies Inc. - Defense World
Anika Therapeutics announces COO departure, streamlines management By Investing.com - Investing.com Canada
Anika Therapeutics announces COO departure, streamlines management - Investing.com
Anika Therapeutics Announces COO Departure and Role Elimination - TipRanks
Viscosupplementation Market Outlook: Growth Drivers - openPR.com
Anika Therapeutics stock hits 52-week low at $13.7 - Investing.com Australia
Anika Therapeutics stock hits 52-week low at $13.7 By Investing.com - Investing.com South Africa
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Anika Grants 3,800 Share Options to New Hire: Key Details Revealed - Stock Titan
Anika Therapeutics, Inc. (NASDAQ:ANIK) Position Trimmed by HighTower Advisors LLC - Defense World
Are Options Traders Betting On A Big Move In Anika Therapeutics (ANIK) Stock? - Barchart.com
Are Options Traders Betting on a Big Move in Anika Therapeutics (ANIK) Stock? - TradingView
Viscosupplementation Market Is Booming Worldwide | Anika - openPR.com
Europe Viscosupplementation Market Projected To Witness - openPR.com
Anika Therapeutics stock hits 52-week low at $14.9 By Investing.com - Investing.com South Africa
Anika Therapeutics stock hits 52-week low at $14.9 - Investing.com India
How the (ANIK) price action is used to our Advantage - news.stocktradersdaily.com
Anika Therapeutics, Inc. (NASDAQ:ANIK) Stock Position Reduced by Charles Schwab Investment Management Inc. - Defense World
Hammertoe Solution Market Size, Trends 2031 By Key Players- - openPR.com
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Acquired by Bank of New York Mellon Corp - Defense World
Europe Viscosupplementation Market Set to Witness Significant - openPR.com
Reviewing Anika Therapeutics (NASDAQ:ANIK) and InspireMD (NYSE:NSPR) - Defense World
Anika Therapeutics Faces Financial Strain Amid Geopolitical Tensions and Supply Chain Disruptions - TipRanks
Anika Therapeutics, Inc. SEC 10-K Report - TradingView
Viscosupplementation Market Is Booming Worldwide | Anika Therapeutics Inc., Seikagaku Corporation - openPR.com
Q1 Earnings Forecast for ANIK Issued By Barrington Research - Defense World
Anika Therapeutics (NASDAQ:ANIK) Stock Rating Upgraded by StockNews.com - Defense World
Barrington Research Lowers Anika Therapeutics (NASDAQ:ANIK) Price Target to $20.00 - Defense World
Anika Therapeutics (NASDAQ:ANIK investor three-year losses grow to 45% as the stock sheds US$26m this past week - Simply Wall St
Anika Therapeutics Full Year 2024 Earnings: Misses Expectations - Yahoo
Anika Therapeutics stock hits 52-week low at $15.34 By Investing.com - Investing.com Australia
Anika Therapeutics’ Earnings Call: Growth Amid Challenges - TipRanks
Anika Therapeutics stock hits 52-week low at $15.34 - Investing.com
Earnings call transcript: Anika Therapeutics Q4 2024 beats EPS forecast, stock dips - Investing.com Australia
Anika Therapeutics Inc (ANIK) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges - Yahoo Finance
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):